{"id":"https://openalex.org/W2171772467","doi":"https://doi.org/10.1111/j.1365-2125.2006.02579.x","title":"Orphan drug development is progressing too slowly","display_name":"Orphan drug development is progressing too slowly","publication_year":2006,"publication_date":"2006-01-20","ids":{"openalex":"https://openalex.org/W2171772467","doi":"https://doi.org/10.1111/j.1365-2125.2006.02579.x","mag":"2171772467","pmid":"https://pubmed.ncbi.nlm.nih.gov/16487232","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1885013"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2125.2006.02579.x","doi":"https://doi.org/10.1111/j.1365-2125.2006.02579.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2006.02579.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2006.02579.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2006.02579.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079498687","display_name":"Roberta Joppi","orcid":"https://orcid.org/0000-0002-9085-3626","observed_orcids":["https://orcid.org/0000-0002-9085-3626","https://orcid.org/0009-0006-3842-9728"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Roberta Joppi","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Milan, Italy","Pharmaceutical Department, Local Health Unit, Verona, Italy","\u2032Mario Negri\u2032 Institute for Pharmacological Research, Milan and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Milan, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Pharmaceutical Department, Local Health Unit, Verona, Italy","institution_ids":[]},{"raw_affiliation_string":"\u2032Mario Negri\u2032 Institute for Pharmacological Research, Milan and","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058646798","display_name":"Vittorio Bertel\u00e8","orcid":"https://orcid.org/0000-0002-0032-7033","observed_orcids":["https://orcid.org/0000-0002-0032-7033"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Vittorio Bertele","raw_affiliation_strings":["\u2032Mario Negri\u2032 Institute for Pharmacological Research, Milan and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2032Mario Negri\u2032 Institute for Pharmacological Research, Milan and","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073550160","display_name":"Silvio K. Garattini","orcid":"https://orcid.org/0000-0003-0647-9297","observed_orcids":["https://orcid.org/0000-0003-0647-9297"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Silvio Garattini","raw_affiliation_strings":["\u2032Mario Negri\u2032 Institute for Pharmacological Research, Milan and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2032Mario Negri\u2032 Institute for Pharmacological Research, Milan and","institution_ids":["https://openalex.org/I19630809"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5073550160"],"corresponding_institution_ids":["https://openalex.org/I19630809"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":15.7385,"has_fulltext":true,"cited_by_count":68,"citation_normalized_percentile":{"value":0.98729823,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"61","issue":"3","first_page":"355","last_page":"360"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.8438000082969666,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.8438000082969666,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.065700002014637,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.046799998730421066,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/orphan-drug-designation","display_name":"orphan drug designation","score":0.828000009059906},{"id":"https://openalex.org/keywords/orphan-drug-approval","display_name":"orphan drug approval","score":0.781000018119812},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.7409999966621399},{"id":"https://openalex.org/keywords/european-public-assessment-reports","display_name":"European Public Assessment Reports","score":0.777999997138977},{"id":"https://openalex.org/keywords/surrogate-endpoints","display_name":"surrogate endpoints","score":0.7289999723434448},{"id":"https://openalex.org/keywords/active-comparator","display_name":"active comparator","score":0.6320000290870667},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.8360000252723694},{"id":"https://openalex.org/keywords/drug-development-incentives","display_name":"drug development incentives","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C56666940","wikidata":"https://www.wikidata.org/wiki/Q788790","display_name":"Documentation","level":2,"score":0.7906184196472168},{"id":"https://openalex.org/C75480439","wikidata":"https://www.wikidata.org/wiki/Q1367466","display_name":"Orphan drug","level":2,"score":0.7300818562507629},{"id":"https://openalex.org/C29122968","wikidata":"https://www.wikidata.org/wiki/Q1414816","display_name":"Incentive","level":2,"score":0.6546993851661682},{"id":"https://openalex.org/C3020782553","wikidata":"https://www.wikidata.org/wiki/Q8880","display_name":"European commission","level":3,"score":0.6457549929618835},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5156818628311157},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.46596649289131165},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.45754358172416687},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4559413194656372},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.43060046434402466},{"id":"https://openalex.org/C2780871342","wikidata":"https://www.wikidata.org/wiki/Q7883752","display_name":"Underpinning","level":2,"score":0.43040919303894043},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4301929473876953},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3493010103702545},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.33804553747177124},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2826610207557678},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.1533517837524414},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.12735286355018616},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.12085685133934021},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10996636748313904},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.08546578884124756},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C175444787","wikidata":"https://www.wikidata.org/wiki/Q39072","display_name":"Microeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C147176958","wikidata":"https://www.wikidata.org/wiki/Q77590","display_name":"Civil engineering","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C105639569","wikidata":"https://www.wikidata.org/wiki/Q582577","display_name":"Economic policy","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004282","descriptor_name":"Documentation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005062","descriptor_name":"European Union","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006307","descriptor_name":"Health Systems Agencies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012106","descriptor_name":"Research","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1365-2125.2006.02579.x","doi":"https://doi.org/10.1111/j.1365-2125.2006.02579.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2006.02579.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2006.02579.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1885013","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1885013","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:16487232","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16487232","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2125.2006.02579.x","doi":"https://doi.org/10.1111/j.1365-2125.2006.02579.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2006.02579.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2006.02579.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.504800021648407,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2171772467.pdf","grobid_xml":"https://content.openalex.org/works/W2171772467.grobid-xml"},"referenced_works_count":1,"referenced_works":["https://openalex.org/W1497692860"],"related_works":["https://openalex.org/W1967601852","https://openalex.org/W2954469623","https://openalex.org/W2051366497","https://openalex.org/W3006232484","https://openalex.org/W2406229511","https://openalex.org/W1966456594","https://openalex.org/W2968501142","https://openalex.org/W1776398781","https://openalex.org/W2064376930","https://openalex.org/W196745762"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"assess":[2],"the":[3,15,32,35,43,90,94,99],"methodological":[4,63],"quality":[5],"of":[6,18,34,50,71,78,84,101],"OMP":[7,52],"dossiers":[8,60],"and":[9,27,38,41,76,89],"to":[10],"discuss":[11],"possible":[12],"reasons":[13],"for":[14,87],"small":[16],"number":[17,100],"products":[19],"licensed.":[20],"METHODS:":[21],"Information":[22],"about":[23],"orphan":[24],"drug":[25],"designation":[26],"approval":[28],"was":[29],"obtained":[30],"from":[31,42],"website":[33],"European":[36,44,85],"Commission-Enterprise":[37],"Industry":[39],"DG":[40],"Public":[45],"Assessment":[46],"Reports.":[47],"RESULTS:":[48],"Out":[49],"255":[51],"designations,":[53],"only":[54],"18":[55],"were":[56],"approved":[57],"(7.1%).":[58],"Their":[59],"often":[61],"showed":[62],"limitations":[64],"such":[65],"as":[66],"inappropriate":[67],"clinical":[68],"design,":[69],"lack":[70],"active":[72],"comparator":[73],"where":[74],"available":[75],"use":[77],"surrogate":[79],"end-points.":[80],"CONCLUSIONS:":[81],"The":[82,104],"paucity":[83],"incentives":[86],"manufacturers":[88],"poor":[91],"documentation":[92],"underpinning":[93],"applications":[95],"may":[96],"have":[97],"limited":[98],"new":[102],"OMP.":[103],"over":[105],"5000":[106],"rare":[107],"diseases":[108],"awaiting":[109],"therapy":[110],"are":[111],"an":[112],"important":[113],"public":[114],"health":[115],"issue.":[116]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}